Last updated on February 2020

Interest of the Dosage of Adalimumab Serum Levels in Crohn's Disease Patients for Prevention of Postoperative Recurrence


Brief description of study

Study comparing 2 modalities of Crohn's disease patients postoperative follow-up treated with adalimumab (Humira or biosimilar) : immunomonitoring of adalimumab serum levels versus standard follow-up, which is based on the clinical and biological activity of the disease.

Detailed Study Description

Patients in the experimental arm will have a post-operative follow-up based on the immunomonitoring of serum levels of adalimumab. After ileocolic resection surgery, patients will have a therapeutic optimization of their adalimumab (Humira or biosimilar) treatment, based on their serum residual rate of adalimumab.

Patients in the control group will receive a standard post-operative follow-up, which is based on clinical and biological recurrence.

Clinical Study Identifier: NCT04200547

Find a site near you

Start Over

CHU de Montpellier

Montpellier, France
  Connect »